Search Browse Earnings

RAPT Therapeutics, Inc.

Nasdaq:RAPT

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.5M

-60.0% YoY

FY 2023

Adj. EBITDA

-$125.8M

-8241.4% margin

FY 2024

Net Income

-$116.8M

-7648.9% margin

FY 2024

EPS (Diluted)

-$3.05

FY 2024

Stock Price

$58.01

+0.0%

2026-03-02

52W Range

$5.67 – $58.01

P/E Ratio

-19.0x

Market Cap

$1.6B

Cash

$47.5M

FY 2024

Total Debt

—

Net Cash

$47.5M

FY 2023

Enterprise Value

$1.6B

Debt / EBITDA

0.4x

FY 2023

EV / EBITDA

-12.4x

Employees

—